Barclays initiated coverage of Aveanna (AVAH) with an Equal Weight rating and $5.50 price target Aveanna primarily operates in the private duty nursing business, which is a Medicaid dominant service where demand outpaces supply, the analyst tells investors. While the firm says there may be near-term earnings upside, 2026 Street EBITDA and margin forecasts “look a bit rich” and broader uncertainty around Medicaid policy is likely to slow rate increases, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVAH: